Precision Insights

Our mission is to provide market intelligence and strategic insights that drive disruption and innovation in the precision medicine and life science industry.

Precision Insights

Our mission is to provide market intelligence and strategic vision to drive disruption and innovation in precision medicine.

Latest Insights
Pharma & Biotech
Explainable, Unbiased AI and Computational Systems Pathology: Q&A with Dusty Majumdar and Chakra Chennubhotla of SpIntellx
DeciBio interviews Dusty Majumdar and Chakra Chennubhotla, CEO and CTO at SpIntellx.
September 22, 2022
Pharma & Biotech
Explainable, Unbiased AI and Computational Systems Pathology: Q&A with Dusty Majumdar and Chakra Chennubhotla of SpIntellx
DeciBio interviews Dusty Majumdar and Chakra Chennubhotla, CEO and CTO at SpIntellx.
September 22, 2022
Clinical Diagnostics
Digital Pathology for Biomarker Development: Decibio’s Q&A with Chan-Young Ock of Lunit
Decibio interviews Dr. Chan-Young Ock of recently IPO’d digital pathology firm, Lunit.
September 12, 2022
Clinical Diagnostics
Digital Pathology for Biomarker Development: Decibio’s Q&A with Chan-Young Ock of Lunit
Decibio interviews Dr. Chan-Young Ock of recently IPO’d digital pathology firm, Lunit.
September 12, 2022
Clinical Diagnostics
Oncologist Perspectives on the Most Exciting Advancements in Precision Medicine
DeciBio conducted a pulse survey with 8 U.S. oncologists to ascertain what precision oncology advancements excite them the most.
September 15, 2022
Clinical Diagnostics
Oncologist Perspectives on the Most Exciting Advancements in Precision Medicine
DeciBio conducted a pulse survey with 8 U.S. oncologists to ascertain what precision oncology advancements excite them the most.
September 15, 2022
Pharma & Biotech
Mark a Course for the Future – Biomarkers in Cancer Immunotherapy
Here we explore how biomarkers are driving the immuno-oncology landscape. We dive into cutting-edge biomarker research and the challenges facing the field.
September 15, 2022
Pharma & Biotech
Mark a Course for the Future – Biomarkers in Cancer Immunotherapy
Here we explore how biomarkers are driving the immuno-oncology landscape. We dive into cutting-edge biomarker research and the challenges facing the field.
September 15, 2022
Our Work

We work with leading diagnostic, research tools, pharmaceutical, biotech, and health technology companies to tackle challenging strategic questions.

Strategy Consulting

We are experts at conducting strategic overhauls, new product expansions, and commercial due diligence.

Learn More about Us

Data & Platforms

Our team provides bottom-up data products and SaaS platforms, to facilitate decision-making.

VIew all Data & platforms
Client Results

Our Impact

We answer complex market questions regarding innovative technological applications.

Careers

Become a DeciBion

Our team is multi-faceted but united by the "decibionic" energy that drives us to transform the precision medicine field.

Precision Medicine is evolving at a rapid pace

Discover how we can help

Contact Us
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Customer love

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nunc dignissim, mi et varius malesuada Lorem ipsum dolor sit amet, consectetur adipiscing elit.